e-learning
resources
Munich 2006
Monday 04.09.2006
Evaluation of risk factors in community-acquired pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prognostic factors of bacteremic pneumococcal pneumonia (BPP)
M. Garcia-Clemente, J. Allende, F. Alvarez-Navascues, A. Sanchez-Antuña, M. Martinez-Muñiz, J. M. Garcia-Garcia, M. Garcia-Marron, H. Villar (Aviles, Spain)
Source:
Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Session:
Evaluation of risk factors in community-acquired pneumonia
Session type:
Oral Presentation
Number:
3069
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Garcia-Clemente, J. Allende, F. Alvarez-Navascues, A. Sanchez-Antuña, M. Martinez-Muñiz, J. M. Garcia-Garcia, M. Garcia-Marron, H. Villar (Aviles, Spain). Prognostic factors of bacteremic pneumococcal pneumonia (BPP). Eur Respir J 2006; 28: Suppl. 50, 3069
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Prognostic score systems and bacteraemic pneumococcal pneumonia (BPP)
Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections
Year: 2008
Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia
Source: Eur Respir J 2016; 48: 797-807
Year: 2016
Prognostic factors of mortality in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 239s
Year: 2003
Bacteremic vs. non-bacteremic pneumococcal pneumonia in immunocompetent patients: Predictive and prognostic factors
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia
Source: Eur Respir J 2006 Oct 01;28(4):816-823
Year: 2006
Predisposing factors for bacteremia in patients with community-acquired pneumonia and positive pneumococcal urinary antigen
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Value of bacteraemia as an unfavourable prognostic factor for community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 350s
Year: 2006
Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes
Source: Eur Respir J 2014; 43: 545-553
Year: 2013
Biomarkers in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012
Risk factors of community-acquired pneumonia in children
Source: Eur Respir J 2010; 36: 1221-1222
Year: 2010
Biomarkers and severity in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012
The assessment of prognostic rules in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2003; 22: Suppl. 45, 149s
Year: 2003
Sepsis severity predicts outcome in community-acquired pneumococcal pneumonia
Source: Eur Respir J 2007; 30: 517-524
Year: 2007
Risk factors of paediatric community-acquired pneumonia
Source: Eur Respir J 2011; 37: 724-725
Year: 2011
Validation of pneumonia severity models for healthcare-associated pneumonia (HCAP)
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
Absence of leukocytosis in bacteremic pneumococcal pneumonia
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009
Factors influencing in-hospital mortality in community-acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 352s
Year: 2006
Differences in prognostic factors and outcome in community-acquired pneumonias (CAP) caused by viral pathogens (VP) or streptococcus pneumoniae (SP)
Source: Eur Respir J 2001; 18: Suppl. 33, 542s
Year: 2001
Assessment of urinary pneumococcal antigen for etiological diagnosis of community-acquired pneumonia
Source: Annual Congress 2003 - New aspects of community acquired pneumonia
Year: 2003
Prognostic factors of 30 day mortality in HIV infected patients with community-acquired pneumonia
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept